Strategies for managing cytomegalovirus in transplant recipients
RR Razonable - Expert opinion on pharmacotherapy, 2010 - Taylor & Francis
Importance of the field: Cytomegalovirus (CMV) is the most important pathogen that affects
transplant recipients, by directly causing clinical disease and by indirectly reducing patient …
transplant recipients, by directly causing clinical disease and by indirectly reducing patient …
Cytomegalovirus infections in solid organ transplantation: a review
P Ramanan, RR Razonable - Infection & chemotherapy, 2013 - synapse.koreamed.org
Cytomegalovirus (CMV) continues to have a tremendous impact in solid organ
transplantation despite remarkable advances in its diagnosis, prevention and treatment. It …
transplantation despite remarkable advances in its diagnosis, prevention and treatment. It …
Cytomegalovirus in transplantation – challenging the status quo
Background: Cytomegalovirus (CMV) infection of solid organ transplant (SOT) recipients
causes both ''direct''and ''indirect''effects including allograft rejection, decreased graft and …
causes both ''direct''and ''indirect''effects including allograft rejection, decreased graft and …
Cytomegalovirus infection in organ transplant recipients
PL Hibberd, DR Snydman - Infectious disease clinics of North America, 1995 - Elsevier
Cytomegalovirus (CMV) continues to be responsible for a substantial fraction of the
morbidity and mortality that follows organ transplantation. The three major consequences of …
morbidity and mortality that follows organ transplantation. The three major consequences of …
Cytomegalovirus in solid organ transplant recipients: clinical updates, challenges and future directions
RR Razonable - Current pharmaceutical design, 2020 - ingentaconnect.com
Cytomegalovirus is the classic opportunistic infection after solid organ transplantation. This
review will discuss updates and future directions in the diagnosis, prevention and treatment …
review will discuss updates and future directions in the diagnosis, prevention and treatment …
Update on cytomegalovirus in transplant recipients: New agents, prophylaxis, and cell-mediated immunity
O Manuel, RK Avery - Current opinion in infectious diseases, 2021 - journals.lww.com
The past 1–2 years have seen major developments in the area of CMV management in
transplant recipients. Expanding diagnostic and therapeutic capabilities provide a …
transplant recipients. Expanding diagnostic and therapeutic capabilities provide a …
New developments in the management of cytomegalovirus infection after solid organ transplantation
AJ Eid, RR Razonable - Drugs, 2010 - Springer
Despite remarkable advances in the diagnostic and therapeutic modalities for its
management, cytomegalovirus (CMV) remains one of the most important pathogens …
management, cytomegalovirus (CMV) remains one of the most important pathogens …
Cytomegalovirus in solid organ transplantation: epidemiology, prevention, and treatment
E Beam, RR Razonable - Current infectious disease reports, 2012 - Springer
Cytomegalovirus (CMV) is one of the most important pathogens that infect solid organ
transplant recipients. CMV is associated with increased morbidity and mortality in this …
transplant recipients. CMV is associated with increased morbidity and mortality in this …
Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients
AT Rowshani, FJ Bemelman, EMM van Leeuwen… - …, 2005 - journals.lww.com
Primary cytomegalovirus (CMV) infection is a major cause of morbidity and mortality in
recipients after solid organ transplantation (SOT). Widespread and prolonged use of antiviral …
recipients after solid organ transplantation (SOT). Widespread and prolonged use of antiviral …
[HTML][HTML] CMV: prevention, diagnosis and therapy
CN Kotton - American Journal of Transplantation, 2013 - Elsevier
Cytomegalovirus (CMV) is the most common infection after organ transplantation and has a
major impact on morbidity, mortality and graft survival. Optimal prevention, diagnosis and …
major impact on morbidity, mortality and graft survival. Optimal prevention, diagnosis and …